Allurion Technologies Inc (ALUR)
1.26
+0.14
(+12.50%)
USD |
NYSE |
Jul 02, 16:00
1.23
-0.03
(-2.38%)
Pre-Market: 05:31
Allurion Technologies SG&A Expense (TTM): 88.24M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 88.24M |
| December 31, 2023 | 92.88M |
| September 30, 2023 | 86.44M |
| Date | Value |
|---|---|
| June 30, 2023 | 73.02M |
| March 31, 2023 | 70.29M |
| December 31, 2022 | 65.77M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
65.77M
Minimum
Dec 2022
92.88M
Maximum
Dec 2023
79.44M
Average
79.73M
Median
SG&A Expense (TTM) Benchmarks
| Outset Medical Inc | 137.84M |
| Paragon 28 Inc | 190.42M |
| Perspective Therapeutics Inc | 19.11M |
| Xtant Medical Holdings Inc | 72.60M |
| Asensus Surgical Inc | 34.07M |